Quick Answer
Sana Biotechnology, Inc. reported Shares Outstanding of 266.73 million shares for fiscal year 2025.
Sana Biotechnology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 266.73M | +19.1% |
| 2024 | 223.92M | +13.2% |
| 2023 | 197.86M | +3.6% |
| 2022 | 191.02M | +3.3% |
| 2021 | 184.93M | +1043.7% |
| 2020 | 16.17M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 262.26M | +17.6% | +13.8% |
| June 30, 2025 | 230.51M | +3.7% | +2.2% |
| March 31, 2025 | 225.46M | +1.9% | +0.7% |
| December 31, 2024 | 223.92M | +13.2% | +0.4% |
| September 30, 2024 | 223.11M | +13.2% | +0.4% |
| June 30, 2024 | 222.21M | +12.9% | +0.4% |
| March 31, 2024 | 221.29M | +15.6% | +11.8% |
| December 31, 2023 | 197.86M | +3.6% | +0.4% |
- Sana Biotechnology, Inc. showed an increase of +19.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Sana Biotechnology, Inc.’s shares outstanding has grown by 1549.5% (from 16.17 million shares to 266.73 million shares).
- The most recent figure is from Sana Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: